These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 9679555

  • 21. Glutathione homeostasis in human hepatic cells: overexpression of gamma-glutamylcysteine synthetase gene in cell lines resistant to buthionine sulfoximine, an inhibitor of glutathione synthesis.
    Tanaka T, Uchiumi T, Kohno K, Tomonari A, Nishio K, Saijo N, Kondo T, Kuwano M.
    Biochem Biophys Res Commun; 1998 May 19; 246(2):398-403. PubMed ID: 9610371
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
    Moscow JA, Townsend AJ, Cowan KH.
    Mol Pharmacol; 1989 Jul 19; 36(1):22-8. PubMed ID: 2747627
    [Abstract] [Full Text] [Related]

  • 24. Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma.
    Asakura T, Imai A, Ohkubo-Uraoka N, Kuroda M, Iidaka Y, Uchida K, Shibasaki T, Ohkawa K.
    Oncol Rep; 2005 Sep 19; 14(3):601-7. PubMed ID: 16077962
    [Abstract] [Full Text] [Related]

  • 25. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
    Johansson K, Ito M, Schophuizen CM, Mathew Thengumtharayil S, Heuser VD, Zhang J, Shimoji M, Vahter M, Ang WH, Dyson PJ, Shibata A, Shuto S, Ito Y, Abe H, Morgenstern R.
    Mol Pharm; 2011 Oct 03; 8(5):1698-708. PubMed ID: 21851097
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
    Tew KD, Monks A, Barone L, Rosser D, Akerman G, Montali JA, Wheatley JB, Schmidt DE.
    Mol Pharmacol; 1996 Jul 03; 50(1):149-59. PubMed ID: 8700107
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
    Cole SP, Downes HF, Mirski SE, Clements DJ.
    Mol Pharmacol; 1990 Feb 03; 37(2):192-7. PubMed ID: 1968221
    [Abstract] [Full Text] [Related]

  • 30. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.
    Hayes JD, Pulford DJ.
    Crit Rev Biochem Mol Biol; 1995 Feb 03; 30(6):445-600. PubMed ID: 8770536
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells.
    Chen G, Waxman DJ.
    Biochem Pharmacol; 1995 May 26; 49(11):1691-701. PubMed ID: 7786310
    [Abstract] [Full Text] [Related]

  • 33. Hepatocytes isolated from preneoplastic rat livers are resistant to ethacrynic acid cytotoxicity.
    Parody JP, Alvarez Mde L, Quiroga A, Ronco MT, Francés D, Carnovale C, Carrillo MC.
    Arch Toxicol; 2007 Aug 26; 81(8):565-73. PubMed ID: 17340122
    [Abstract] [Full Text] [Related]

  • 34. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S, Dutta P, Mookerjee A, Choudhuri SK.
    Chem Biol Interact; 2006 Feb 01; 159(2):90-103. PubMed ID: 16289015
    [Abstract] [Full Text] [Related]

  • 35. Combined expression of multidrug resistance protein (MRP) and glutathione S-transferase P1-1 (GSTP1-1) in MCF7 cells and high level resistance to the cytotoxicities of ethacrynic acid but not oxazaphosphorines or cisplatin.
    Morrow CS, Smitherman PK, Townsend AJ.
    Biochem Pharmacol; 1998 Oct 15; 56(8):1013-21. PubMed ID: 9776312
    [Abstract] [Full Text] [Related]

  • 36. Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression.
    Nagata J, Kijima H, Hatanaka H, Asai S, Miyachi H, Takagi A, Miwa T, Mine T, Yamazaki H, Nakamura M, Kondo T, Scanlon KJ, Ueyama Y.
    Biochem Biophys Res Commun; 2001 Aug 17; 286(2):406-13. PubMed ID: 11500053
    [Abstract] [Full Text] [Related]

  • 37. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance.
    Harbottle A, Daly AK, Atherton K, Campbell FC.
    Int J Cancer; 2001 Jun 15; 92(6):777-83. PubMed ID: 11351295
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.
    Tipnis SR, Blake DG, Shepherd AG, McLellan LI.
    Biochem J; 1999 Feb 01; 337 ( Pt 3)(Pt 3):559-66. PubMed ID: 9895302
    [Abstract] [Full Text] [Related]

  • 39. Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid.
    Singh SV, Xu BH, Maurya AK, Mian AM.
    Biochim Biophys Acta; 1992 Nov 17; 1137(3):257-63. PubMed ID: 1445927
    [Abstract] [Full Text] [Related]

  • 40. Enhanced gamma-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity.
    Das GC, Bacsi A, Shrivastav M, Hazra TK, Boldogh I.
    Mol Carcinog; 2006 Sep 17; 45(9):635-47. PubMed ID: 16491484
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.